GlassScriptPhysician profile
Lina Anthony
NPI 1679522874
$6,350.98
in general payments reported to CMS, 2019-2025
46 companies · $1,349 in 2025
The $1,349 reported for 2025 was more than what 82% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.72 · 2020: $58.62 · 2021: $967 · 2022: $1,304 · 2023: $1,510 · 2024: $1,150 · 2025: $1,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,930 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,929.53 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $721.54 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $645.32 | 2021-2025 | Trelegy Ellipta, Nucala |
| United Therapeutics Corporation | $496.25 | 2021-2025 | Tyvaso, Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $423.42 | 2021-2025 | Cyltezo, Jascayd, Jardiance |
| Pulmonx Corporation | $390.29 | 2022-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Actelion Pharmaceuticals US, INC. | $364.96 | 2021-2025 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $261.98 | 2022-2024 | Yupelri |
| Insmed, INC. | $219.93 | 2021-2025 | Arikayce, Brinsupri |
| Amgen INC. | $190.03 | 2021-2024 | Tezspire, Evenity, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.06 | 2021-2023 | Xifaxan |
| Baxter Healthcare | $166.58 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Regeneron Healthcare Solutions, INC. | $148.09 | 2021-2025 | Dupixent |
| Ardelyx, INC. | $146.74 | 2022-2024 | Ibsrela |
| Inspire Medical Systems, INC. | $135.07 | 2024-2025 | Inspire |
| Merck Sharp & Dohme LLC | $134.84 | 2022-2025 | Zerbaxa, Recarbrio, Dificid |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $129.40 | 2022-2025 | Omvoh, Zepbound |
| Celgene Corporation | $123.79 | 2021-2024 | Zeposia |
| Mirati Therapeutics, INC. | $122.49 | 2023 | Krazati |
| Horizon Therapeutics Plc | $115.88 | 2022 | |
| Abbvie INC. | $114.47 | 2021-2024 | Mavyret |
| Grifols USA, LLC | $108.67 | 2020-2023 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $90.58 | 2022 | |
| Gilead Sciences, INC. | $89.99 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $77.21 | 2021-2024 | |
| Electromed, INC. | $73.16 | 2021-2025 | Smartvest |
| Covis Pharma Gmbh | $72.70 | 2021-2022 | |
| Advanced Respiratory, INC | $64.06 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.44 | 2022-2023 | Gattex |
| Janssen Biotech, INC. | $47.26 | 2020-2024 | Stelara |
| Redhill Biopharma INC. | $47.25 | 2021-2023 | Talicia |
| Abbott Laboratories | $47.08 | 2022-2023 | Proclaim |
| Genentech USA, INC. | $41.54 | 2019-2023 | Xolair |
| Boston Scientific Corporation | $38.78 | 2021-2024 | Embold Fibered |
| Qol Medical, LLC | $31.89 | 2024 | Sucraid |
| Phathom Pharmaceuticals, INC. | $30.09 | 2024 | Voquezna |
| Impulse Dynamics (USA) INC. | $29.78 | 2022-2023 | Optimizer |
| Viatris Specialty LLC | $29.14 | 2025 | Yupelri |
| Ethicon INC. | $25.48 | 2022 | |
| Genzyme Corporation | $21.07 | 2023 | |
| Phadia US INC. | $19.13 | 2023 | Immunocap |
| Hologic Sales and Service, LLC | $17.38 | 2023 | Aptima |
| Teva Pharmaceuticals USA, INC. | $15.46 | 2021 | |
| Philips North America LLC | $13.90 | 2025 | Vest Therapy Und |
| Braintree Laboratories, INC. | $12.11 | 2022 | |
| Daiichi Sankyo INC. | $11.18 | 2021 | |
| 3b Medical, INC. | $6.52 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lina Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.